A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
Reported byScienceAlert ↗·Sourced by Goodlede
A 3-year-old boy with hepatoblastoma that had metastasized to his lungs and bones achieved complete regression after receiving two infusions of experimental GPC3-CAR T cell therapy in the CARE trial, remaining disease-free 12 months later after chemotherapy and surgery had failed.
This is a single-patient case report from a clinical trial; broader efficacy and safety across hepatoblastoma and other GPC3+ solid tumors require further study.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceAlert
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede